Memory Pharmaceuticals to Present at BIO InvestorForum 2005
Montvale, NJ - October 12, 2005 - Memory Pharmaceuticals Corp. (NASDAQ: MEMY) today announced that Jim Sulat, President and Chief Executive Officer, will provide a Company update at the BIO InvestorForum 2005 on October 19th at 10:40 a.m. PDT, at the Palace Hotel in San Francisco.
Interested parties may access a live audio webcast of the presentation by visiting the Investor Relations section of Memory Pharmaceuticals' website at http://www.memorypharma.com. An archived version of the webcast will be available at the same location through October 25, 2005.
About the Company
Memory Pharmaceuticals Corp., a biopharmaceutical company, is focused on developing innovative drugs for the treatment of debilitating CNS disorders such as Alzheimer's disease, schizophrenia, depression, vascular dementia, mild cognitive impairment, Parkinson's disease and memory impairments associated with aging. For additional information, please visit our website at http://www.memorypharma.com.